Vanguard Group’s KalVista Pharmaceuticals KALV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.3M | Buy |
2,412,399
+113,801
| +5% | +$1.29M | ﹤0.01% | 2408 |
|
2025
Q1 | $26.5M | Buy |
2,298,598
+43,355
| +2% | +$500K | ﹤0.01% | 2376 |
|
2024
Q4 | $19.1M | Buy |
2,255,243
+104,716
| +5% | +$887K | ﹤0.01% | 2610 |
|
2024
Q3 | $24.9M | Buy |
2,150,527
+159,939
| +8% | +$1.85M | ﹤0.01% | 2482 |
|
2024
Q2 | $23.4M | Buy |
1,990,588
+305,475
| +18% | +$3.6M | ﹤0.01% | 2490 |
|
2024
Q1 | $20M | Sell |
1,685,113
-96,306
| -5% | -$1.14M | ﹤0.01% | 2596 |
|
2023
Q4 | $21.8M | Buy |
1,781,419
+48,930
| +3% | +$599K | ﹤0.01% | 2555 |
|
2023
Q3 | $16.7M | Buy |
1,732,489
+151,808
| +10% | +$1.46M | ﹤0.01% | 2617 |
|
2023
Q2 | $14.2M | Sell |
1,580,681
-1,845
| -0.1% | -$16.6K | ﹤0.01% | 2750 |
|
2023
Q1 | $12.4M | Buy |
1,582,526
+429,853
| +37% | +$3.38M | ﹤0.01% | 2822 |
|
2022
Q4 | $7.79M | Buy |
1,152,673
+2,812
| +0.2% | +$19K | ﹤0.01% | 3067 |
|
2022
Q3 | $16.7M | Sell |
1,149,861
-7,297
| -0.6% | -$106K | ﹤0.01% | 2709 |
|
2022
Q2 | $11.4M | Sell |
1,157,158
-9,494
| -0.8% | -$93.4K | ﹤0.01% | 2921 |
|
2022
Q1 | $17.2M | Buy |
1,166,652
+28,168
| +2% | +$415K | ﹤0.01% | 2854 |
|
2021
Q4 | $15.1M | Sell |
1,138,484
-48,263
| -4% | -$639K | ﹤0.01% | 2988 |
|
2021
Q3 | $20.7M | Buy |
1,186,747
+222,328
| +23% | +$3.88M | ﹤0.01% | 2846 |
|
2021
Q2 | $23.1M | Buy |
964,419
+34,938
| +4% | +$837K | ﹤0.01% | 2765 |
|
2021
Q1 | $23.9M | Buy |
929,481
+361,933
| +64% | +$9.3M | ﹤0.01% | 2693 |
|
2020
Q4 | $10.8M | Buy |
567,548
+8,695
| +2% | +$165K | ﹤0.01% | 2957 |
|
2020
Q3 | $7.04M | Sell |
558,853
-479
| -0.1% | -$6.03K | ﹤0.01% | 2974 |
|
2020
Q2 | $6.77M | Sell |
559,332
-861
| -0.2% | -$10.4K | ﹤0.01% | 2948 |
|
2020
Q1 | $4.29M | Buy |
560,193
+10,174
| +2% | +$77.8K | ﹤0.01% | 3035 |
|
2019
Q4 | $9.8M | Buy |
550,019
+5,971
| +1% | +$106K | ﹤0.01% | 2868 |
|
2019
Q3 | $6.31M | Buy |
544,048
+16,219
| +3% | +$188K | ﹤0.01% | 3047 |
|
2019
Q2 | $11.7M | Buy |
527,829
+170,439
| +48% | +$3.78M | ﹤0.01% | 2773 |
|
2019
Q1 | $10.2M | Buy |
357,390
+16,547
| +5% | +$474K | ﹤0.01% | 2810 |
|
2018
Q4 | $6.73M | Buy |
340,843
+44,262
| +15% | +$874K | ﹤0.01% | 2950 |
|
2018
Q3 | $6.56M | Buy |
296,581
+179,092
| +152% | +$3.96M | ﹤0.01% | 3135 |
|
2018
Q2 | $954K | Buy |
117,489
+394
| +0.3% | +$3.2K | ﹤0.01% | 3702 |
|
2018
Q1 | $1.11M | Sell |
117,095
-1,243
| -1% | -$11.8K | ﹤0.01% | 3627 |
|
2017
Q4 | $1.15M | Sell |
118,338
-81,280
| -41% | -$793K | ﹤0.01% | 3577 |
|
2017
Q3 | $1.33M | Buy |
199,618
+18,746
| +10% | +$125K | ﹤0.01% | 3516 |
|
2017
Q2 | $1.3M | Buy |
180,872
+100
| +0.1% | +$720 | ﹤0.01% | 3510 |
|
2017
Q1 | $1.41M | Buy |
180,772
+141,476
| +360% | +$1.11M | ﹤0.01% | 3487 |
|
2016
Q4 | $278K | Sell |
39,296
-387,372
| -91% | -$2.74M | ﹤0.01% | 3836 |
|
2016
Q3 | $196K | Sell |
426,668
-118,071
| -22% | -$54.2K | ﹤0.01% | 3906 |
|
2016
Q2 | $361K | Sell |
544,739
-12,819
| -2% | -$8.5K | ﹤0.01% | 3847 |
|
2016
Q1 | $358K | Buy |
557,558
+144,031
| +35% | +$92.5K | ﹤0.01% | 3854 |
|
2015
Q4 | $1.5M | Buy |
413,527
+125,242
| +43% | +$453K | ﹤0.01% | 3502 |
|
2015
Q3 | $1.03M | Buy |
288,285
+63,173
| +28% | +$225K | ﹤0.01% | 3620 |
|
2015
Q2 | $1.61M | Buy |
+225,112
| New | +$1.61M | ﹤0.01% | 3506 |
|